10x genomics wins another patent infringement case against nanostring technologies

Jury awards 10x genomics over $31 million in damages and finds all seven asserted patents valid and willfully infringed by nanostring geomx decision is third ruling against nanostring, showing serial infringement of 10x patents pleasanton, calif., nov. 17, 2023 /prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, announced today that a jury in the u.s. district court for the district of delaware has reached a unanimous verdict in favor of 10x genomics in the patent infringement suit 10x filed against the geomx products sold by nanostring technologies, inc. (nasdaq: nstg).
NSTG Ratings Summary
NSTG Quant Ranking